Table 6.
25(OH) vitamin D levels and vitamin D deficiency prevalence among the different disease outcomes and characteristics in non-severe COVID-19 patients (n.37)
| 25(OH) vitamin D levels (ng/mL) | P value | ||
|---|---|---|---|
| Hospitalization, yes/no | Yes (n.26): 14.1 [9.6–25] | No (n.11): 13.2 [9.8–22] | 0.78 |
|
Worsening, yes/no |
Yes (n.10): 8.6 [5.7–14] | No (n.27): 16.7 [11.4–31] | 0.004 |
| NIMV, yes/no | Yes (n.2): 6.2 [5.8–6.3] | No (n.35): 14.4 [10.6–23.1] | 0.04 |
| ICU, yes/no | Yes (n.1): 5.8 [5.8–5.8] | No (n.36): 14.1 [10.1–22.9] | 0.22 |
| ALI-ARDS, yes/no | Yes (n.14): 11 [5.7–18.9] | No (n.23): 15.9 [11.4–28.7] | 0.03 |
| Hyperinflammation, yes/no | Yes (n.14): 11.2 [7.9–19.1] | No (n.23): 16.7 [11.4–23.1] | 0.21 |
| Vitamin D deficiency, n. (%) | |||
|---|---|---|---|
| Hospitalization, yes/no | Yes: 18 (69%) | No: 8 (73%) | >0.99 |
|
Worsening, yes/no |
Yes: 10 (100%) | No: 16 (59%) | 0.018 |
| NIMV, yes/no | Yes: 2 (100%) | No: 24 (68%) | >0.99 |
| ICU, yes/no | Yes: 1 (100%) | No: 25 (69%) | >0.99 |
| ALI-ARDS, yes/no | Yes: 12 (86%) | No: 14 (61%) | 0.15 |
| Hyperinflammation, yes/no | Yes: 11 (78%) | No: 15 (65%) | 0.47 |
n. number, NIMV non-invasive mechanical ventilation, ICU intensive care unit, ALI Acute Lung Injury, ARDS Acute Respiratory-Distress Syndrome
P values reported in bold are those statistically significant